business

Rocket Pharmaceuticals (RCKT) Reports Q1 2026 Net Loss of $47.6M

Yahoo Finance · May 18, 2026, 4:50 AM · Also reported by 3 other sources

Read full story on Yahoo Finance → More top stories

Also covered by

Investing.com Catheter Precision reports 200% revenue growth in Q1 2026 Investing.com Earnings call transcript: Arvinas Inc. reports Q1 2026 earnings, stock reacts Investing.com Earnings call transcript: Atea Pharmaceuticals Q1 2026 reveals stock plunge after EPS miss

Aggregated and edited by the Scoop newsroom. We surface news from Yahoo Finance alongside other reporting so you can compare coverage in one place. Editorial policy · Corrections · About Scoop

Rocket Pharmaceuticals (RCKT) Reports Q1 2026 Net Loss of $47.6M

Also covered by

More in business